Respiratory Medications in Infants <29 Weeks during the First Year Postdischarge: The Prematurity and Respiratory Outcomes Program (PROP) Consortium

Rita M. Ryan(Medical University of South Carolina), Michael Sacilowski, Susan Kelley, Karin L. Knowles, Erna Josiah-Davis, Shannon Castiglione, Karen Martin(Minnesota Department of Health), Roberta L. Keller(City College of San Francisco), Brenda B. Poindexter(Cincinnati Children's Hospital Medical Center), Cathy Grigsby, Katrina Burson, Pamela A. Shaw(University of Pennsylvania), Odessa L. Settles, Mark O’ Hunt, Jeanette Asselin, Julie Arldt-McAlister, Sharon Wadley, Cheryl Chapin, Georgia E. McDavid, Beth Koch(University of California, San Francisco), M. Layne Lillie, Shawna Rodgers, Kelly Thornton, Julie Hoffmann, Christopher McPherson(St. Louis Children's Hospital), Daniel K. Sperry, Jayne Sicard-Su, Deanna Maffet, Claudia Cleveland, Scarlett L. Bellamy(California University of Pennsylvania), Aimee Horan, Gina Simpson, Amy B. Beller, Tari L. Gratton, Samantha Balan, Laura Linneman, Paul E. Moore(Vanderbilt University), Christopher N. Johnson, James M. Greenberg, Carmen Garcia, Sarah K. Martin, Carl T. D’Angio(University of Rochester), Jane O’Donnell, Lori Pacello(AdventHealth for Children), Rick Hinojosa, Steven Steele, Pamela Bates(University of Pennsylvania), Barbara D. Alexander(Duke University), Theresa J. Rogers, Hart Horneman
The Journal of Pediatrics
March 8, 2019
Cited by 37


Related Papers